tengotinib | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

49 results for “tengotinib”

Trials

View all 39 →

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

56 participants · First posted Sep 11, 2023

Tepotinib Hepatic Impairment Trial

18 participants · First posted Jun 6, 2018

Rollover Study to Provide Continued Access to TT-00420 (Tinengotinib) for Subjects With Advanced Solid Tumors

First posted Apr 17, 2024

Drugs

Investigational

Tinengotinib

C₂₀H₁₉ClN₆O

Tepotinib(Tepmetko)

Conditions: Metastatic Non-Small Cell Lung Cancer

C₂₉H₂₈N₆O₂ · Rx

News

Allist's Jetientai (tengotinib) included in CSCO diagnosis and treatment guidelines

FDA Approves FoundationOne Liquid CDx as Companion Diagnostic for Tepotinib in METex14-Skipping NSCLC

TransThera's Tinengotinib Receives Priority Review Status in China for Advanced Cholangiocarcinoma Treatment

Page 1 of 5